Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Hexarelin

Examorelin, HEX

A synthetic hexapeptide growth hormone secretagogue that stimulates GH release by acting on the ghrelin receptor in the pituitary and hypothalamus.

Quick Stats
Studies 233
Trials 61
Formula C47H58N12O6
Clear All
Utility 3
pubmed 1994

Growth hormone (GH)-releasing hormone secretion is stimulated by a new GH-releasing hexapeptide in sheep.

Guillaume. V V; Magnan. E E; Cataldi. M M; Dutour. A A; Sauze. N N; Renard. M M; Razafindraibe. H H;...

A single IV dose of hexarelin in sheep quickly boosted growth hormone levels, mainly by making the brain release more GHRH, while not affecting the hormone that normally blocks GH. This shows hexarelin works not just directly on the pituitary but also by activating brain signals that tell the pituitary to release GH.

Utility 3
pubmed Oct 31, 2006

Ghrelin reduces injury of hippocampal neurons in a rat model of cerebral ischemia/reperfusion.

Liu. Yajun Y; Wang. Paulus S PS; Xie. Dongping D; Liu. Kejing K; Chen. Lianbi L

In rats, giving the hormone ghrelin after a brief loss of blood flow to the brain helped protect memory‑related hippocampal cells, keeping more of them alive and cutting down cell death. This shows ghrelin can act like a brain‑protective drug in this animal model.

Utility 3
pubmed 1997

Hexarelin, a growth hormone-releasing peptide, discloses protectant activity against cardiovascular damage in rats with isolated growth hormone deficiency.

De Gennaro Colonna. V V; Rossoni. G G; Bernareggi. M M; Müller. E E EE; Berti. F F

In rats that lack growth hormone, the heart and blood vessels don’t work well, but giving them the peptide hexarelin for two weeks fixes the hormone levels and restores normal heart and vessel function. This shows hexarelin can reverse damage caused by growth‑hormone deficiency, at least in animals.

Utility 3
pubmed 1995

Radioimmunoassay for hexarelin, a peptidic growth hormone secretagogue, and its pharmacokinetic studies.

Roumi. M M; Lenaerts. V V; Boutignon. F F; Wuthrich. P P; Deghenghi. R R; Bellemare. M M; Adam. A A;...

This study created a very sensitive test to measure hexarelin and measured how the peptide behaves in dogs after injection. It found that after an IV dose, hexarelin stays in the blood for about two hours and is cleared at a steady rate, while sub‑cutaneous injections show consistent clearance across a wide dose range. Although the work is in dogs, the clear pharmacokinetic numbers give hobbyists a rough idea of how long the drug lasts and how dosing might scale, but human data are still needed.

Utility 3
pubmed 1995

Comparison of the effects of growth hormone-releasing hormone and hexarelin, a novel growth hormone-releasing peptide-6 analog, on growth hormone secretion in humans with or without glucocorticoid excess.

Giustina. A A; Bussi. A R AR; Deghenghi. R R; Imbimbo. B B; Licini. M M; Poiesi. C C; Wehrenberg. W...

The study shows that a single IV dose of hexarelin (100 µg) can boost growth hormone levels in people whose GH release is suppressed by high steroid levels, doing so as well as in healthy volunteers, whereas the usual GH‑releasing hormone (GHRH) works poorly in that situation.

Utility 3
pubmed 1994

Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects.

Arvat. E E; Gianotti. L L; Grottoli. S S; Imbimbo. B P BP; Lenaerts. V V; Deghenghi. R R; Camanni. F...

The study shows that the peptide hexarelin can trigger a strong growth‑hormone (GH) surge in both young and older men, but the boost is smaller in the elderly. Adding growth‑hormone‑releasing hormone (GHRH) makes the response even bigger, especially in younger people. In older participants, mixing hexarelin with the amino‑acid arginine dramatically improves the GH release, while arginine has little effect in the young.

Utility 3
pubmed 1995

Modulation of growth hormone-releasing activity of hexarelin in man.

Arvat. E E; Gianotti. L L; Di Vito. L L; Imbimbo. B P BP; Lenaerts. V V; Deghenghi. R R; Camanni. F...

Hexarelin is a synthetic six‑amino‑acid peptide that makes the pituitary release a lot of growth hormone (GH). In healthy men it worked better than the natural GH‑releasing hormone (GHRH) and gave an even bigger GH spike when used together with GHRH. Somatostatin, which normally blocks GH, could almost completely stop GHRH‑induced GH but only reduced the effect of hexarelin.

Utility 3
pubmed 1995

Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, before and during puberty.

Bellone. J J; Aimaretti. G G; Bartolotta. E E; Benso. L L; Imbimbo. B P BP; Lenhaerts. V V; Deghengh...

Hexarelin, a synthetic six‑amino‑acid peptide, makes the body release a lot of growth hormone (GH). In kids it worked better than the natural GH‑releasing hormone, especially at higher doses, and even an oral pill gave a boost. The GH surge was bigger during puberty and was strongest in girls.

Utility 3
pubmed 1995

The effect of hexarelin on growth hormone (GH) secretion in patients with GH deficiency.

Loche. S S; Cambiaso. P P; Merola. B B; Colao. A A; Faedda. A A; Imbimbo. B P BP; Deghenghi. R R; Lo...

Hexarelin, a synthetic six‑amino‑acid peptide, can boost growth hormone (GH) release when given intravenously at 2 µg/kg, but only in people whose hypothalamus‑pituitary connection is still working. It works well in kids with idiopathic GH deficiency, similar to normal short kids, but fails in those whose pituitary area is damaged or disconnected.

Utility 3
pubmed 1995

The growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, in short normal and obese children and in hypopituitary subjects.

Loche. S S; Cambiaso. P P; Carta. D D; Setzu. S S; Imbimbo. B P BP; Borrelli. P P; Pintor. C C; Capp...

Hexarelin is a synthetic six‑amino‑acid peptide that, when given by IV at 2 µg per kilogram, triggers a strong, quick rise in growth hormone (GH) in normal and overweight children, but not in people who lack a functioning pituitary. The GH boost is bigger than that from standard GHRH, works in both boys and girls, and is even stronger after a short testosterone priming. No serious side effects were seen, though cortisol and prolactin rose a bit and then fell back to normal.

Utility 3
pubmed 2000

Kinetics and disposition of hexarelin, a peptidic growth hormone secretagogue, in rats.

Roumi. M M; Marleau. S S; du Souich. P P; Maggi. T T; Deghenghi. R R; Ong. H H

In rats, the peptide hexarelin stays in the blood for about 1.3 hours after an IV dose and is well absorbed when injected under the skin, with about two‑thirds of the dose reaching the bloodstream. Most of the unchanged peptide is cleared through bile, and it’s relatively stable against breakdown.

Utility 3
pubmed Apr 1, 1997

Non-parametric deconvolution provides an objective assessment of GH responsiveness to GH-releasing stimuli in normal subjects.

Sartorio. A A; De Nicolao. G G; Pizzini. G G; Liberati. D D

The study shows that a single dose of hexarelin (1 µg/kg) triggers a strong growth‑hormone (GH) surge that peaks within the first hour, and a second dose given just two hours later produces a much smaller GH release (only 13‑36% of the first). It also proves that you don’t need a long, dense blood‑sampling schedule to see this effect – measuring GH up to 60 minutes after the injection is enough.

Utility 3
pubmed 1994

Growth hormone releasing activity by intranasal administration of a synthetic hexapeptide (hexarelin).

Laron. Z Z; Frenkel. J J; Gil-Ad. I I; Klinger. B B; Lubin. E E; Wuthrich. P P; Boutignon. F F; Leng...

A tiny synthetic peptide called hexarelin can boost growth hormone (GH) when sprayed into the nose, working almost as well as an IV injection. In a small study of 12 people (mostly kids with short stature), GH rose sharply, while thyroid hormone levels stayed normal. Adults who truly lack GH did not respond.

Utility 2
pubmed Jul 27, 2012

Chronic administration of hexarelin attenuates cardiac fibrosis in the spontaneously hypertensive rat.

Xu. Xiangbin X; Ding. Fan F; Pang. Jinjiang J; Gao. Xue X; Xu. Rong-Kun RK; Hao. Wei W; Cao. Ji-Min...

In a rat model of high blood pressure, giving the peptide hexarelin for five weeks lowered heart scarring, reduced heart muscle thickening, improved heart function, and lowered blood pressure. These benefits depended on the peptide’s specific receptor, because blocking the receptor stopped the effects.

Utility 2
pubmed Jan 15, 2008

New trisubstituted 1,2,4-triazole derivatives as potent ghrelin receptor antagonists. 3. Synthesis and pharmacological in vitro and in vivo evaluations.

Moulin. Aline A; Demange. Luc L; Ryan. Joanne J; Mousseaux. Delphine D; Sanchez. Pierre P; Berg&#xe9...

Researchers made two new chemicals that can block the appetite‑boosting effect of the peptide hexarelin in animal tests, but they don’t change growth‑hormone levels. These compounds aren’t currently available as supplements or drugs for personal use.

Utility 2
pubmed Feb 7, 2024

Pharmacological targeting of the hyper-inflammatory response to SARS-CoV-2-infected K18-hACE2 mice using a cluster of differentiation 36 receptor modulator.

Gauvin. Jade J; Huynh. David N DN; Dubuc. Isabelle I; Lê. Catherine C; Tugores. Rafaela R; Flam...

Researchers gave mice infected with the COVID‑19 virus a synthetic peptide called hexarelin, which can bind to a cell‑surface protein (CD36) that helps drive the harmful inflammation seen in severe disease. In the mouse model, hexarelin changed the behavior of lung immune cells, lowering the flood of inflammatory signals that can cause breathing failure. The work is still early‑stage and done only in animals, so it isn’t a ready‑to‑use treatment for people yet.

Utility 2
pubmed Jan 21, 2022

Using Synchrotron Radiation Imaging Techniques to Elucidate the Actions of Hexarelin in the Heart of Small Animal Models.

Waddingham. Mark T MT; Tsuchimochi. Hirotsugu H; Sonobe. Takashi T; Asano. Ryotaro R; Jin. Huiling H...

The study shows that giving hexarelin once can widen tiny heart blood vessels in rats, but giving it over a long time does not stop right‑heart problems caused by high blood pressure in the lungs. The research used very advanced X‑ray imaging, so it’s more about understanding how the peptide works than giving a clear health tip.

Utility 2
pubmed Nov 29, 2021

Hexarelin attenuates abdominal aortic aneurysm formation by inhibiting SMC phenotype switch and inflammasome activation.

Jiang. Bo B; Wang. Mo M; Li. Xue X; Ren. Pengwei P; Li. Guangxin G; Wang. Yuqi Y; Wang. Lei L; Li. X...

In a mouse study, the growth‑hormone‑releasing peptide hexarelin helped prevent the widening of the abdominal aorta that leads to aneurysms. It kept the vessel wall's elastic fibers intact, kept smooth‑muscle cells in a healthy state, and lowered inflammation by blocking key immune pathways.

Utility 2
pubmed Nov 1, 2009

Use of coated capillaries for the electrophoretic separation of stereoisomers of a growth hormone secretagogue.

Nehmé. Reine R; Perrin. Catherine C; Guerlavais. Vincent V; Fehrentz. Jean-Alain JA; Cottet. He...

The study shows how to reliably separate and measure the different 3‑D forms (stereoisomers) of the peptide hexarelin using a special coated capillary in an electrophoresis test. By coating the capillary with a positively charged polymer, the test becomes fast (about 12 minutes) and repeatable, avoiding the problem of the peptide sticking to the tube.